Incidence and Factors Associated With Androgenetic Alopecia Among Transgender and Gender-Diverse Patients Treated With Masculinizing Hormone Therapy
February 2021
in “
JAMA Dermatology
”
Studysummary Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jamanetwork.com →